Site Search
Search Results
Oncologists Call for Improvements in Access to Biomarker Testing as Assembly Insurance Committee Signals Unanimous Support
... 17, 2023 – Earlier today, oncologists and cancer survivors from across New York gathered at the Capitol to answer lawmakers’ questions about biomarker testing and ask for their support of Senate Bill 1196 / Assembly Bill 1673. This legislation, which is being sponsored by Asm. Pamela Hunter and Sen. Roxanne Persaud and maintains bipartisan support, aims to improve New Yorkers’ access to precision medicine through biomarker testing. Biomarker testing has become a game-changing part of cancer care given its role in opening the door to targeted treatments that ...
Cancer Survivors Rally for New Yorkers’ Access to Precision Medicine, Urge Governor Hochul to Sign Biomarker Testing Bill
... today, cancer survivors gathered at Buffalo’s City Hall alongside health care providers and patient advocates to emphasize the importance of biomarker testing for the health of New York State, its people and its potential for an equitable, hope-filled future. Attendees of the rally called on ... 1673a and reject any attempts to weaken the bill by limiting its scope. Senate Bill 1196a / Assembly Bill 1673a seeks to ensure comprehensive biomarker testing is covered by all state-regulated health plans, including Medicaid, when medically appropriate. The bill passed the Legislature ...
Patient Advocates Rally in Times Square for New Yorkers’ Access to Precision Medicine, Urge Governor Hochul to Sign Biomarker Testing Legislation
... Earlier today, cancer survivors gathered in Times Square alongside health care providers and patient advocates to emphasize the importance of biomarker testing for the health of New York State, its people and its potential for an equitable, hope-filled future. Attendees of the rally called on Governor Hochul to sign Senate Bill 1196a / Assembly Bill 1673a and reject any attempts to weaken the bill by limiting its scope. Biomarker testing enables physicians to match patients with personalized care and improve patient quality of life by avoiding ineffective, invasive ...
Calls to Improve New Yorkers’ Access to Precision Medicine Through Biomarker Testing Bring Together Patients and Providers from across Disease Spectrum
... seeks to improve New Yorkers’ access to precision medicine, requiring all state-regulated health plans, including Medicaid, to cover biomarker testing when it is supported by medical and scientific evidence. Over 60 organizations have rallied together in support of the legislation, citing the efficacy of and praising the innovation in precision medicine. Biomarker testing is a tool utilized by physicians across a variety of specialties to connect patients to the right treatment at the right time. ...
Texas Becomes Latest State to Improve Access to Biomarker Testing, Beating New York in Push to Prioritize Precision Medicine
... TX – MAY 30, 2023 – Yesterday, Texas Governor Greg Abbott signed Senate Bill 989 into law, making Texas the 11 th state to expand access to biomarker testing. New York is considering comparable legislation through Assembly Bill 1673 / Senate Bill 1196. The American Cancer Society Cancer Action ... responded to the legislative victory in Texas with the following statement: “Texas has joined a growing list of states expanding access to biomarker testing. The clock is ticking for New York to do the same. We cannot wait any longer to act on Assembly Bill 1673 / Senate Bill 1196. ...
NYS Senate Rejects Medicaid Rollback of Biomarker Testing Coverage Criteria, Patient Advocates Urge Governor & Assembly to Follow Suit in Final Budget
... of disease. The New York State Senate flatly rejected the governor’s proposal to roll back Medicaid coverage criteria for biomarker testing, heeding the calls of cancer survivors, patient advocates and public health organizations, like the American Cancer Society Cancer ... Clinical practice guidelines are the most frequently consulted resource in deciding whether to recommend or order biomarker testing, cited by 91% of oncology providers in a recent survey. In response, Michael Davoli, who serves as the senior government ...
Legislation Aimed at Improving Health Outcomes for New Yorkers Awaits Governor's Action
ALBANY, NY – JUNE 9, 2023 – Late last night, the New York State Assembly passed Assembly Bill 1673a to increase access to biomarker testing, which can help determine the best treatment plan for each patient. The bill will now go to Governor Hochul’s desk, providing her the ... (ACS CAN) is sponsoring this significant policy change to ensure more cancer patients can get the testing needed to access precision medicine. Biomarker testing has become a game-changing part of cancer care given its role in opening the door to targeted treatments that can lead to ...
Public Health Champions Unite to Applaud Senate and Urge Assembly and Governor Hochul “Reject the Rollback”
... to applaud the Senate and call on Governor Hochul and Assembly leadership to join the Senate in preserving Medicaid enrollees’ access to biomarker testing. The conversation around equitable access to biomarker testing was reignited earlier this year, when Governor Hochul proposed to eliminate the existing coverage criteria for Medicaid enrollees ...
Governor Hochul Signs Game-Changing Legislation Aimed at Improving Health Outcomes, Quality of Life for New Yorkers
... a major win for patients across New York. The new law will require all state-regulated health plans, including Medicaid, to cover comprehensive biomarker testing, which will enable more New Yorkers to access precision medicine treatments that can lead to fewer side effects, improved survival, better ... fight against cancer and improve access to the most effective treatments, giving patients a better chance of living longer, healthier lives.” Biomarker testing has become a game-changing part of cancer care given its role in opening the door to personalized care, including targeted ...
Colorectal Cancer Awareness Month 2023: What Has New York Done to Address Rise in Colorectal Cancer Diagnoses?
... the New York State Legislature aims to improve access to precision medicine for patients with cancer and other diseases by expanding access to biomarker testing. Building off the progress of the Colorectal Cancer Cost-Sharing Removal Act, which was passed at the end of 2022 and will remove financial barriers to screening, Senate Bill 1196 / Assembly Bill 1673 will ensure that New Yorkers who could benefit from biomarker testing have access to it, including those with CRC. The proposed legislation will require all state-regulated health plans, including ...